{"schema_version":"secwatch.filing_event.v1","accession":"0001040130-23-000078","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.988672+00:00","generated_at":"2026-06-09T05:31:00.343227+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"PetMed Express Q2 net loss of $70k; suspends quarterly dividend to invest in growth","bullets":["Net sales $71.0M (+9% YoY); net loss $70k vs $2.6M income; diluted EPS ($0.00) vs $0.13.","Adjusted EBITDA $3.2M, down 55% from $7.1M, citing acquisition costs and strategic investments.","Board suspends quarterly dividend, shifting capital allocation to organic and inorganic growth initiatives.","New customers up 25% YoY; AutoShip & Save and PetPlus programs account for 51% of revenue, up from 39%."],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-23-000078","json":"https://secwatch.observer/filing/0001040130-23-000078.json","markdown":"https://secwatch.observer/filing/0001040130-23-000078.md","text":"https://secwatch.observer/filing/0001040130-23-000078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013023000078/0001040130-23-000078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013023000078/pets-20231030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T05:31:00.343227+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7c786ff5ac5c02df8c4920927df777a43fbc3d27","claim":"PETMED EXPRESS INC reported its second quarter ended September 30, 2023 results: revenue $71.0 million, net income Net loss for the quarter ended September 30, 2023 was $70 thousand, or $(0.00) per diluted share, EPS $(0.00) per diluted share.","evidence_excerpt":"TM , today announced its financial results for its second quarter ended September 30, 2023. Quarterly Highlights • Net sales for the quarter ended September 30, 2023, were $71.0 million, compared to $65.4 million for the second quarter in the prior year, an increase of 9% year over year. The current quarter includes the results from the recent acquisition of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1040130/000104013023000078/0001040130-23-000078-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"its second quarter ended September 30, 2023"},{"label":"Revenue","value":"$71.0 million"},{"label":"Net income","value":"Net loss for the quarter ended September 30, 2023 was $70 thousand, or $(0.00) per diluted share"},{"label":"EPS","value":"$(0.00) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}